Valbiotis (XPAR:ALVAL) Accounts Payable & Accrued Expense : €1.95 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Accounts Payable & Accrued Expense?

Valbiotis's quarterly accounts payable & accrued expense declined from Dec. 2022 (€1.66 Mil) to Jun. 2023 (€1.58 Mil) but then increased from Jun. 2023 (€1.58 Mil) to Dec. 2023 (€1.95 Mil).

Valbiotis's annual accounts payable & accrued expense increased from Dec. 2021 (€1.54 Mil) to Dec. 2022 (€1.66 Mil) and increased from Dec. 2022 (€1.66 Mil) to Dec. 2023 (€1.95 Mil).

Valbiotis Accounts Payable & Accrued Expense Historical Data

The historical data trend for Valbiotis's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Accounts Payable & Accrued Expense Chart

Valbiotis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.75

1.51

1.54

1.66

1.95

Valbiotis Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial											1.54	1.20	1.66	1.58	1.95

Valbiotis Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Valbiotis (XPAR:ALVAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

8JD:Germany

Address

12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180

Website

http://www.valbiotis.com

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines